CHALFONT ST. GILES, UK – 1 November 2016 – GE Healthcare’s Life Sciences business, a global provider of expertise, tools and technologies to the biotech industry, announced today a USD 7 million expansion project at its single-use technology manufacturing facility in Westborough, MA, US. The expanded site will manufacture a range of single-use products, including... Read more
GE Healthcare and LifeWatch announce an intent to develop a strategic relationship Milwaukee – 24 October 2016 – GE Healthcare today announced that it has signed a letter of intent with LifeWatch AG (SIX Swiss Exchange: LIFE), a leading developer and provider of medical solutions and remote diagnostic monitoring services in the digital health market.... Read more
Chicago – 21 October 2016 – In the lead up to ANESTHESIOLOGY® 2016, the annual meeting of the American Society of Anesthesiologists (ASA) in Chicago, GE Healthcare today announced the global commercial launch of Carestation™ Insights. This growing family of analytics applications is designed to harness the power of data from connected anesthesia machines and... Read more
Mumbai, October 17, 2016: Tata Trusts and GE Healthcare today announced a partnership to train 10,000 youth in various technical areas of healthcare over a three-year period. The partnership will focus on bridging the skills gap in healthcare technical or operating staff. The announcement was made in the presence of Mr. Ratan Tata, Chairman of... Read more
Chalfont St. Giles, UK – September 22, 2016 – The Automated Breast Ultrasound (ABUS) system is found to have significantly improved cancer detection in women with dense breast tissue when used together with mammography. The European Asymptomatic Screening Study aimed to evaluate the impact of ABUS in conjunction with full field digital screening mammography (FFDSM)... Read more
CHALFONT ST. GILES, UK – 30 September 2016 –At the International Society for Cellular Therapy’s Regional Meeting in Memphis, TN, GE Healthcare’s recently acquired Biosafe Group introduces Sefia, a state-of-the-art, multi-function platform which uses a combination of continuous-flow centrifugation, temperature control and fluidic management to enable purification, concentration, washing and final formulation during cell processing. Combined with GE... Read more
Chalfont St. Giles, UK and Songdo, Korea – 29 September 2016 – GE Healthcare’s Life Sciences business, a global provider of technologies and expertise to the biopharmaceutical and life sciences industries, announced today the opening of a GE Fast Trak Center in Songdo, Incheon Metropolitan City, South Korea. The new USD 7.4 million Center will... Read more
Rome – 22 September 2016 – GE Healthcare and Trice Imaging, Inc., a cloud-based medical imaging solutions provider, today announced a commercial partnership to provide a new way for clinicians to connect with their colleagues and patients. This solution – called Tricefy™ – adds cloud-based image sharing, diagnostic collaboration, remote reviewing, archiving and Electronic Health Record... Read more
CHALFONT ST. GILES, UK and YAROSLAVL, RUSSIA – 22 September 2016 – R-Pharm Group has opened an innovative biopharmaceutical production plant equipped with GE Healthcare’s FlexFactory™ manufacturing platform in Yaroslavl, Russia. R-Pharm’s FlexFactory will support the mass production of biologics and biosimilars focused on treating autoimmune diseases and cancer, and allowing for increased access to these... Read more
CORK – 19 September, 2016 – Ireland’s Minister for Jobs, Enterprise and Innovation, Mary Mitchell O’Connor TD, today announced that GE (NYSE:GE) is to invest €150 million in a new biopharmaceutical manufacturing campus on Industrial Development Agency (IDA) Ireland’s strategic site at Loughbeg, Ringaskiddy, Co. Cork. GE BioPark Cork, subject to contract and planning approvals,... Read more